Corvus Pharmaceuticals Inc.

12/17/2024 | Press release | Distributed by Public on 12/17/2024 15:06

Corvus Pharmaceuticals to Announce Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on December 18, 2024

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.